Benjamin Pradere

Sep 30, 2024 | europeanurology.com | Roger Li |Joshua A. Linscott |James Catto |Joshua J. Meeks |Siamak Daneshmand |Bishoy M Faltas | +4 more

Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes aDepartment of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USAbDepartment of Immunology, H.

Aug 10, 2024 | nature.com | Benjamin Pradere

AbstractWe aimed to evaluate the correlation between endoscopic papillary abnormalities (PA) and high renal papilla Hounsfield density (PHD) on CT scan in patients who underwent flexible ureteroscopic treatment (fURS) for renal stones. We retrospectively assessed patients from a prospectively collected database who were treated with fURS for renal stones between May 2016 and October 2020.

Nov 7, 2023 | europeanurology.com | Marcin Miszczyk |IIIrd Radiotherapy |Markus von Deimling |Benjamin Pradere

AbstractDespite the lack of level 1 evidence, metastasis-directed therapy (MDT) is used widely in the management of metastatic prostate cancer (mPCa) patients. Data are continuously emerging from well-designed prospective studies. To summarise and report the evidence on oncological and safety outcomes of MDT in the management of mPCa patients.

Aug 10, 2023 | bjui-journals.onlinelibrary.wiley.com | Ekaterina Laukhtina |Markus von Deimling |Benjamin Pradere |Takafumi Yanagisawa

BCa bladder cancer EORTC-QLQ-C30 European Organization for Research and Treatment of Cancer–Quality of Life Questionnaire–Cancer 30 FSFI Female Sexual Function Index HRQOL health-related quality of life IC ileal conduit ISC intermittent self-catheterization NSRC nerve-sparing radical cystectomy ONB orthotopic neobladder RC radical cystectomy ROBINS-I Risk of bias in non-randomized studies of interventions tool ROPRC reproductive organ-preserving radical cystectomy SF short-form Introduction...

Jan 28, 2023 | europeanurology.com | Benjamin Pradere |Quint Fonsegrives |Giuseppe Basile |Thomas Seisen

We read with interest the trial by Lindgren et al. [], which showed that short-term intensive chemoresection using six mitomycin (MMC) instillations over a 2-wk period without any preceding biopsy for recurrent Ta low- or high-grade non–muscle-invasive bladder cancer (NMIBC) resulted in significantly fewer patients in need of a procedure within 2 yr of diagnosis as compared with standard treatment.